bluuebunny/crossref_metadata_2025_split huggingface dataset:
Potencial de Inundação e Erosão do Parque Natural Municipal de Jacarenema, Vila Velha-ES (Flood and erosion potential of the municipal natural park of Jacarenema, Vila Velha-ES)
Authors: Pinheiro Carlos Alberto Kuster , Eguchi Branco Mateus Murata , Wanderley Thayana Caus , Alves Rodolfo Teixeira , Araújo Renato Ferreira de , Albino Jacqueline 
Published: November 2018

No presente trabalho foi realizado o mapeamento da vulnerabilidade do Parque Natural Municipal de Jacarenema, localizado no município de Vila Velha/ES, frente a eventos de erosão e inundação causados pela elevação do nível do mar, segundo previsão do Painel Intergovernamental Sobre Mudanças Climáticas (IPCC, 2014). Os resultados obtidos indicam grande perda de terreno, principalmente nas áreas de brejo, restinga e manguezal, o que pode acarretar em diversos impactos para a região, como a perda de habitat de diversas espécies, a salinização da água doce, a perda de áreas recreativas e turísticas do Parque e conflitos na ocupação de terrenos por moradores no entorno da UC. A B S T R A C TIn the present work, the level of vulnerability within the Jacarenema Municipal Natural Park, Vila Velha / ES was assessed. This vulnerability is in regards to erosion and flood, caused by sea level rise. Sea level rise prediction was retrieved from the Intergovernmental Panel on Climate change. The results indicate a loss of land equivalent to 40.24 ha (11.62% of the total), mainly in the areas of swamp, restinga and mangrove. This can lead to several impacts to the region. Such as salinization of fresh water, loss of habitat, recreational and tourist areas within the Park. Also, generating conflicts of occupation by residents in the surroundings of the conservation unit (CU).Keywords: Conservation Units, Coastal Vulnerability, Ground Covering.
Being Inside and Outside Social Relations
Authors: Rapport Nigel 
Published: November 2018

It is a special responsibility to incur individual readings of one’s work from colleagues. I hope the following line of thought does them justice.Nay Rather, an essay by Anne Carson (a translator and poet as well as a classical scholar), begins with an account of the trial of Joan of Arc. Caught in battle against the English and their Burgundian allies on 23 May 1430, a year after she had assisted a French army in lifting the English siege of Orleans, Joan of Arc was put on trial for heresy. The trial lasted from January to May 1431, and Joan was burnt at the stake on 30 May, aged nineteen. In recounting this history, Carson explains that she is particularly interested in the way in which, as she puts it, Joan was ‘distant’ from her own words. Carson (2014: 8) elaborates. Joan of Arc’s guidance, military and moral came from a source that she called ‘voices’. She began to hear them at the age of twelve, and they commanded her style of dress, her beliefs and the revolutionary politics of her action. At her trial, her English ecclesiastical prosecutors wanted to know her voices, for Joan to name and describe them in ways in which they might understand: in terms of recognised religious imagery and emotions, and in a conventional narrative that might then be subjected to mechanisms of theological proof.
Gamma Knife surgery for large cerebral arteriovenous malformations
Authors: Kim Hae Yu , Chang Won Seok , Kim Dong Joon , Lee Jae Whan , Chang Jin Woo , Kim Dong Ik , Huh Seung Kon , Park Yong Gou , Chang Jong Hee 
Published: November 2018

Object
Treatment of arteriovenous malformations (AVMs) is problematic due to many factors, including lesion size, lesion location, unacceptable complications, and negative outcomes. To overcome the limitation imposed by a large nidus volume, neurosurgeons have used Gamma Knife surgery (GKS) in a variety of ways, including combined with other treatment modalities, as volume-staged radiosurgery, and as repeat radiosurgery. We performed repeat radiosurgeries in patients who harbored large AVMs (> 30 cm3) and analyzed the AVM obliteration rates and complications.

Methods
The authors reviewed the cases of 44 patients at a single institution who underwent GKS between 1992 and 2007 for treatment of an AVM whose nidus was 30 cm3 or larger. The mean age of the patients was 27 years (range 4.5–62.3 years), and the median duration of follow-up was 109.4 months (range 27–202 months). The mean AVM nidus volume was 48.8 cm3 (range 30.3–109.5 cm3), and the mean radiation dose delivered to the margin of the nidus was 13.9 Gy (range 8.4–17.5 Gy). The authors determined complete AVM nidus obliteration based on findings on both MR images and digital subtraction angiograms. When they did not detect complete obliteration after GKS, they performed 1 or more additional GKSs separated by a minimum interval of 3 years.

Results
The overall obliteration rate following repeat GKS was 34.1%, and the estimated obliteration rate at 120 months was 41.8%. Three patients (6.8%) experienced hemorrhages after GKS, and 2 patients (4.5%) developed cysts. One patient (2.3%) experienced a newly developed seizure following GKS, and another patient (2.3%) was found to have radiation necrosis.

Conclusions
Even though complete obliteration of the large AVMs after repeat GKS took a long time, the complication rate was quite acceptable. In addition, the estimated obliteration rate at long-term follow-up was respectable. Repeat GKS should be considered as a primary treatment option for symptomatic large AVMs to overcome the limitation imposed on successful obliteration by the large volume of the nidus.
Does the Gamma Knife dose rate affect outcomes in radiosurgery for trigeminal neuralgia?
Authors: Arai Yoshio , Kano Hideyuki , Lunsford L. Dade , Novotny Josef , Niranjan Ajay , Flickinger John C. , Kondziolka Douglas 
Published: November 2018

Object
The object of this study was to determine whether the radiation dose rate affects clinical outcomes in patients who undergo stereotactic Gamma Knife surgery (GKS) to manage typical trigeminal neuralgia (TN).

Methods
The authors retrospectively studied pain relief in 165 patients with medically intractable TN, who underwent 80-Gy GKS using a single 4-mm collimator between 1994 and 2005. No patient had received prior radiation treatment. The measured relative helmet output factor of the Gamma Knife was 0.8 throughout this interval, and the dose rate varied from 1.21 Gy/minute to 3.74 Gy/minute (median 2.06 Gy/minute). Irradiation time varied from 26.73 to 95.11 minutes. The authors divided patients into a low-dose-rate (LDR) group, in which the dose rate varied from 1.21 to 2.05 Gy/minute, and a high-dose-rate (HDR) group, in which the dose rate varied from 2.06 to 3.74 Gy/minute. Post-GKS, the patients' pain control was determined using the Barrow Neurological Institute (BNI) pain scale.
There was no statistically significant difference between groups with respect to history of prior microvascular decompression (p = 0.410) or peripheral neuroablative procedures (p = 0.583). The length of symptoms in patients varied from 3 to 414 months with a median of 84 months (p = 0.698). Median follow-up was 26 months with a maximum of 139 months.

Results
Initial pain relief was obtained in 71% of patients in the LDR group and 78% in the HDR group (p = 0.547). Patients who initially obtained improved pain relief (BNI Scores I–IIIa) after GKS maintained pain control for median durations of 52 months (LDR group) and 54 months (HDR group) (p = 0.403). New or increased facial sensory dysfunction was found in 14.5% of patients in the LDR group and in 19.3% of patients in the HDR group (p = 0.479).

Conclusions
The authors found that the GKS dose rate did not affect pain control or morbidity within the range of 1.21–3.74 Gy/minute. Cobalt 60 source decay did not affect outcomes of GKS for TN pain management, even for dose rates approximating a 2-half-life decay of the isotope.
Gamma Knife surgery for hypothalamic hamartomas and epilepsy: patient selection and outcomes
Authors: Abla Adib A. , Shetter Andrew G. , Chang Steve W. , Wait Scott D. , Brachman David G. , Ng Yu-Tze , Rekate Harold L. , Kerrigan John F. 
Published: November 2018

Object
The authors present outcomes obtained in patients who underwent Gamma Knife surgery (GKS) at 1 institution as part of a multimodal treatment of refractory epilepsy caused by hypothalamic hamartomas (HHs).

Methods
Between 2003 and 2010, 19 patients with HH underwent GKS. Eight patients had follow-up for less than 1 year, and 1 patient was lost to follow-up. The 10 remaining patients (mean age 15.1 years, range 5.7–29.3 years) had a mean follow-up of 43 months (range 18–81 months) and are the focus of this report. Five patients had undergone a total of 6 prior surgeries: 1 transcallosal resection of the HH, 2 endoscopic transventricular resections of the HH, 2 temporal lobectomies, and 1 arachnoid cyst evacuation. In an institutional review board–approved study, postoperative complications and long-term outcome measures were monitored prospectively with the use of a proprietary database. Seven patients harbored Delalande Type II lesions; the remainder harbored Type III or IV lesions. Seizure frequency ranged from 1–2 monthly to as many as 100 gelastic seizures daily. The mean lesion volume was 695 mm3 (range 169–3000 mm3, median 265 mm3). The mean/median dose directed to the 50% isodose line was 18 Gy (range 16–20 Gy). The mean maximum point dose to the optic chiasm was 7.5 Gy (range 5–10 Gy). Three patients underwent additional resection 14.5, 21, and 32 months after GKS.

Results
Of the 10 patients included in this study, 6 are seizure free (2 after they underwent additional surgery), 1 has a 50%–90% reduction in seizure frequency, 2 have a 50% reduction in seizure frequency, and 1 has observed no change in seizure frequency. Overall quality of life, based on data obtained from follow-up telephone conversations and/or surveys, improved in 9 patients and was due to improvements in seizure control (9 patients), short-term memory loss (3 patients), and behavioral symptoms (5 patients); in 1 patient, quality of life remains minimally affected. Incidences of morbidity were all temporary and included poikilothermia (1 patient), increased depression (1 patient), weight gain/increased appetite (2 patients), and anxiety (1 patient) after GKS.

Conclusions
Of the approximately 150 patients at Barrow Neurological Institute who have undergone treatment for HH, the authors have reserved GKS for treatment of small HHs located distal from radiosensitive structures in patients with high cognitive function and a stable clinical picture, which allows time for the effects of radiosurgery to occur without further deterioration. The lack of significant morbidity and the clinical outcomes achieved in this study demonstrated a low risk of GKS for HH with results comparable to those of previous series.
Gamma Knife surgery for hypothalamic hamartomas causing refractory epilepsy: preliminary results from a prospective observational study
Authors: Mathieu David , Deacon Charles , Pinard Catherine-Andrée , Kenny Brendan , Duval Julie 
Published: November 2018

Object
Hypothalamic hamartomas (HHs) are congenital lesions typically presenting with medically refractory epilepsy. Open or endoscopic surgical procedures to remove or disconnect the hamartoma have been reported to be effective but are associated with significant morbidity. The authors of studies on Gamma Knife surgery for HHs have reported an encouraging rate of epilepsy resolution with minimal side effects. At the Centre Hospitalier Universitaire de Sherbrooke, the authors have undertaken a prospective observational study of the outcomes of patients who underwent radiosurgery for HHs.

Methods
Patients were included in the study if they had an HH, refractory epilepsy, and no other suspected seizure focus. After radiosurgery, seizure status was assessed every 3 months and reported using the Engel Classification. Quality of life evaluation was performed annually using a standardized questionnaire, and neuropsychological evaluation was performed after 2 years.

Results
Nine patients were included in the study. They ranged in age from 12 to 57 years. Epilepsy began in infancy in all cases and was refractory to standard antiepileptic drugs. The patients received an average of 2 antiepileptic drugs before undergoing radiosurgery. Using the Régis Classification, 6 patients had smaller hamartomas (Grade I–III) and underwent treatment of the entire lesion, using a margin dose of 14–20 Gy. Treatment volume ranged from 0.3 to 1.0 ml. Three patients had larger lesions (Grade IV–VI) for which a radiosurgical disconnection was attempted, targeting the area of attachment to the hypothalamus. For those patients, the margin dose was 15 or 16 Gy, with treatment volume ranging from 0.8 to 1.8 ml. In all patients, the radiation dose received by the optic pathways was kept below 10 Gy. Disconnection led to no improvement in epilepsy (Engel Class IV). Four patients in whom the entire lesion was treated are now seizure free (Engel Class I), with another having only rare seizures (Engel Class II). Quality of life and verbal memory were improved in those patients with more than 3 years of follow-up. No adverse event occurred after radiosurgery.

Conclusions
Radiosurgery safely and effectively controlled the epileptic disorder in patients with HHs when the entire lesion could be targeted. Radiosurgical disconnection is ineffective and cannot be recommended.
Prospective evaluation of a dedicated spine radiosurgery program using the Elekta Synergy S system
Authors: Gerszten Peter C. , Novotny Josef , Quader Mubina , Dewald Valerie C. , Flickinger John C. 
Published: November 2018

Object
Cone beam CT (CBCT) image guidance has recently been adopted for the delivery of spine radiosurgery. In 2007, the authors' institution began a dedicated spine radiosurgery program using the Elekta Synergy S system, which incorporates CBCT technology. In this study, the authors prospectively evaluated the Synergy S platform as a dedicated spine radiosurgery delivery system, including an evaluation of the accuracy of patient positioning using this technology, as part of a quality assurance program.

Methods
One hundred sixty-six spine and paraspinal lesions were treated using the Elekta Synergy S 6-MV LINAC with a beam modulator and CBCT image guidance combined with a HexaPOD couch that allows correction of patient positioning in 3 translational and 3 rotational directions. Stratifying the lesion by location, there were 28 cervical, 69 thoracic, 48 lumbar, and 21 sacral lesions. The most common histological types for the metastatic lesions (136 cases total) were breast, lung, sarcomas, and renal cells. The most common benign tumors (30 cases total) included 10 schwannomas, 5 neurofibromas, and 5 meningiomas. Twenty-eight lesions (17%) were intradural. To measure intratreatment patient movement, 3 quality assurance CBCTs were performed and recorded at separate times: immediately before treatment started; at the first third of the procedure; and at the second third of the procedure. The positioning data and fused images of the planning CT and CBCT were analyzed to determine intrafraction patient movements. From each of 3 quality assurance CBCT images, 3 translational and 3 rotational coordinates were obtained.

Results
The prescribed dose to the gross tumor volume, delivered in a single fraction, ranged from 12 to 20 Gy (mean 16 Gy) in this cohort. This dose was delivered by between 7 and 14 coplanar intensity-modulated radiation therapy beams (mean 9 beams). The gross tumor volumes ranged from 1.2 to 491.7 cm3 (mean 39.2 cm3). Mean treatment time including setup was 64 minutes. At the first third of the treatment, the magnitude of the 3D translational vector (X, Y, Z) was 1.1 ± 0.7 mm. Similarly, the 3D translational vector at the second third of the treatment was 1.0 ± 0.6 mm. The means ± SDs of the rotational angles were 0.2° ± 0.4°, 0.4° ± 0.5°, and 0.3° ± 0.5° along yaw, roll, and pitch, respectively, at the first third of the treatment, and 0.2° ± 0.3°, 0.4° ± 0.5°, and 0.4° ± 0.5°, respectively, at the second third of the treatment.

Conclusions
Single-fraction spine radiosurgery performed using the Synergy S platform and incorporating CBCT image guidance was determined to be feasible, accurate, and safe. This technique provides an overall translational position accuracy of < 2.0 mm.
Tumor shrinkage of vestibular schwannomas after Gamma Knife surgery: results after more than 5 years of follow-up
Authors: Nagano Osamu , Serizawa Toru , Higuchi Yoshinori , Matsuda Shinji , Sato Makoto R.T. , Yamakami Iwao , Okiyama Koichi , Ono Junichi , Saeki Naokatsu 
Published: November 2018

Object
The authors prospectively analyzed volume changes in vestibular schwannomas (VSs) after Gamma Knife surgery (GKS).

Methods
Among 104 VSs treated by GKS at the Chiba Cardiovascular Center between 1998 and 2004, 87 consecutively treated unilateral VSs observed on follow-up MR imaging for at least 5 years were analyzed. These lesions were harbored by 31 men and 56 women, with a mean age of 58.6 years (range 29–80 years). The Gd-enhanced volume of each lesion was measured serially every 3 months during the 1st year and every 6 months thereafter using GammaPlan or SurgiPlan. The frequency and degree of volume shrinkage were documented and possible prognostic factors were analyzed.

Results
The mean tumor volume at GKS was 2.5 cm3 (range 0.1–13.2 cm3). The lesions were irradiated by directing a mean dose of 12.0 Gy (range 10.5–13.0 Gy) to the tumor margin, which was located at the mean 52.2% isodose line (range 50%–67% isodose line). The mean follow-up period was 7.5 years (range 5.0–11.1 years). Peak tumor volume expansion was most frequently observed at 8.6 months after GKS and averaged 58% (range 0%–613%). Five years after GKS, the mean reduction in tumor volume was 31%, and 9 tumors still remained larger than their initial volumes. Tumors that homogeneously enhanced on MR images displayed less shrinkage than other tumors.

Conclusions
Most VSs exhibit shrinkage 5 years after GKS. The mean volume reduction in this series was 31%. These results indicate that careful serial follow-up is necessary for patients who harbor tumors that display homogeneous enhancement on MR images and patients whose tumors continue to expand in size after GKS.
Gamma Knife surgery for low-flow cavernous sinus dural arteriovenous fistulas
Authors: Jung Hyun Ho , Chang Jong Hee , Whang Kum , Pyen Jin Soo , Chang Jin Woo , Park Yong Gou 
Published: November 2018

Object
The purpose of this study was to assess the efficacy of Gamma Knife surgery (GKS) for treating cavernous sinus dural arteriovenous fistulas (CSDAVFs).

Methods
Of the 4123 GKSs performed between May 1992 and March 2009, 890 procedures were undertaken to treat vascular lesions. In 24 cases, the vascular lesion that was treated was a dural arteriovenous fistula, and in 6 of these cases, the lesion involved the cavernous sinus. One of these 6 cases was lost to follow-up, leaving the other 5 cases (4 women and 1 man) to comprise the subjects of this study. All 5 patients had more than 1 ocular symptom, such as ptosis, chemosis, proptosis, and extraocular movement palsy. In all patients, CSDAVF was confirmed by conventional angiography. Three patients were treated by GKS alone and 2 patients were treated by GKS combined with transarterial embolization. The median follow-up period after GKS in these 5 cases was 30 months (range 9–59 months).

Results
All patients experienced clinical improvement, and their improvement in ocular symptoms was noticed at a mean of 17.6 weeks after GKS (range 4–24 weeks). Two patients received embolization prior to GKS but did not display improvement in ocular symptoms. An average of 20 weeks (range 12–24 weeks) was needed for complete improvement in clinical symptoms. There were no treatment-related complications during the follow-up period.

Conclusions
Gamma Knife surgery should be considered as a primary, combined, or additional treatment option for CSDAVF in selected cases, such as when the lesion is a low-flow shunt without cortical venous drainage. For those selected cases, GKS alone may suffice as the primary treatment method when combined with close monitoring of ocular symptoms and intraocular pressure.
Intracapsular decompression or radical resection followed by Gamma Knife surgery for patients harboring a large vestibular schwannoma
Authors: Pan Hung-Chuan , Sheehan Jason , Sheu Meei-Ling , Chiu Wen-Ta , Yang Dar-Yu 
Published: November 2018

Object
Microsurgery is the primary treatment used for patients harboring a large vestibular schwannoma (VS). However, its outcome may lead to hearing impairment and facial nerve dysfunction particularly when resection is extended outside the tumor capsule. When surgery for a large VS consists of intracapsular resection and decompression, better preservation of facial and hearing function are obtained. In this study, the authors compared outcomes of intracapsular decompression followed by Gamma Knife surgery (GKS) with outcomes of standard microsurgery followed by radiosurgery.

Methods
Between August 2003 and October 2008, 35 patients harboring large VSs (> 3 cm in diameter) were enrolled in this study. Eighteen patients underwent intracapsular decompression followed by GKS (Group I), and 17 patients underwent radical extracapsular resection followed by GKS (Group II). In all cases GKS was performed with a margin dose of 12 Gy. All patients were followed up for at least 3 years. All patients also underwent periodic audiography, electroneuronography (ENoG), MR imaging, and testing with the SF-36 form. The Student t-test and repeated ANOVA were used for statistical analysis.

Results
The mean ages of the patients (± SEM) in Groups I and II were 50 ± 3.0 and 49 ± 2.3 years, respectively. The female/male ratios were 8:10 in Group I and 7:10 in Group II. All patients had excellent facial function as measured according to the House-Brackmann Facial Grading System (Grade I or II) preoperatively. After the operation, 16 patients (89%) in Group I retained excellent facial function, whereas only 6 patients (35%) in Group II had excellent facial function (p < 0.01). In Group I, 11 patients had serviceable hearing, and all 11 (100%) retained hearing function after the operation. In Group II, 11 patients had serviceable hearing, but none retained hearing function postoperatively (p < 0.001). In Group I, the mean tumor volume (± SEM) was 17.5 ± 1.1 cm3, and the postoperative volume was 9.35 ± 1.02 cm3. In Group II, the mean tumor volume was 16.4 ± 0.95 cm3, whereas the postoperative volume was 1.1 ± 0.14 cm3 (p < 0.001). After GKS, the tumor volume was reduced to 5.12 ± 1.1 cm3 and 0.9 ± 0.1 cm3 in Groups I and II, respectively. No patients experienced adverse effects after GKS. The mean return-to-work times were 2.4 ± 0.16 and 33.4 ± 4.3 weeks in Groups I and II, respectively (p < 0.001). According to the results obtained using the 36-Item Short Form Health Survey (SF-36), patients in Group I enjoyed more significant improvements in quality of life than patients in Group II (p < 0.001).

Conclusions
Intracapsular decompression followed by GKS afforded a better neurological outcome and quality of life than radical extracapsular resection followed by GKS. Further application of this approach in patients harboring large VSs seems warranted.